Instylla
Setting a new standard for selectivity, ease, and efficacy for embolization therapy in interventional radiology and oncology.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD164—245m (Dealroom.co estimates Aug 2023.)
Waltham Massachusetts (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | $8.1m | Early VC | |
$25.4m | Series B | ||
* | $30.0m | Late VC | |
| Total Funding | CAD86.6m | ||
Related Content
Recent News about Instylla
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.